Atossa Therapeutics【ATOS】株式ニュース

名称	銘柄コード	市場	種別
Atossa Therapeutics Inc	ATOS	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	0.02	1.79%	1.14	08:55:54

始値	安値	高値	終値	前日終値
1.13	1.11	1.135	1.11	1.12

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/17	21:30	GLOBE	Atossa Set to Join Russell 3000® Index Effective June 28,..
2024/6/05	21:30	GLOBE	Atossa to Present at the Sidoti Small-Cap Investor..
2024/5/28	21:30	GLOBE	Atossa Therapeutics Announces Support of Clinical Study..
2024/5/24	13:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2024/5/23	22:00	EDGAR2	Form DEF 14A - Other definitive proxy statements
2024/5/15	21:30	GLOBE	Atossa Therapeutics Announces Last Patient, Last Dose in its..
2024/5/15	05:46	EDGAR2	Form DEL AM - Delaying amendment
2024/5/14	05:05	EDGAR2	Form S-3 - Registration statement under Securities Act of..
2024/5/13	22:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/13	22:00	EDGAR2	Form 8-K - Current report
2024/5/13	21:50	GLOBE	Atossa Therapeutics Announces First Quarter 2024 Financial..
2024/5/10	22:00	EDGAR2	Form PRE 14A - Other preliminary proxy statements
2024/5/07	21:30	GLOBE	Atossa Therapeutics Announces Support of New Breast Cancer..
2024/4/29	21:30	GLOBE	Atossa Therapeutics Announces Expanded Research Agreement..
2024/4/15	21:30	GLOBE	Atossa Therapeutics and Quantum Leap Healthcare Announce..
2024/4/11	21:30	GLOBE	Atossa to Participate in Noble Capital Markets Emerging..
2024/4/10	00:59	GLOBE	Atossa Therapeutics Presents Data from 40mg Cohort of Phase..
2024/4/02	05:00	GLOBE	Atossa Therapeutics Announces Year-End 2023 Financial..
2024/3/19	21:30	GLOBE	Atossa Therapeutics Provides Five-Year (Z)-Endoxifen..
2024/3/18	21:30	GLOBE	Atossa Therapeutics Regains Compliance with Nasdaq Minimum..
2024/3/12	21:30	GLOBE	Atossa Therapeutics Appoints Breast Cancer Specialist Tessa..
2024/2/22	22:30	GLOBE	Atossa Therapeutics Announces First Patient Dosing of..
2024/2/07	22:30	GLOBE	Atossa Therapeutics Announces Full Enrollment..
2024/1/09	22:30	GLOBE	Atossa Therapeutics Issues Letter to Shareholders
2023/12/04	22:30	GLOBE	Atossa Therapeutics Announces the Appointment of Arezoo..
2023/11/20	22:30	GLOBE	Atossa Therapeutics Announces Full Enrollment of Phase 2..
2023/11/16	06:15	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2023/11/16	06:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/13	23:10	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/13	23:00	EDGAR2	Form 8-K - Current report
2023/11/13	23:00	GLOBE	Atossa Therapeutics Announces Third Quarter 2023 Financial..
2023/11/09	23:00	EDGAR2	Form 8-K - Current report
2023/11/09	23:00	GLOBE	Atossa Therapeutics Appoints Financial Executive Jonathan..
2023/10/31	02:00	PRNUS	Quantum Leap Healthcare Collaborative Initiates Landmark..
2023/10/17	05:00	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2023/10/11	21:30	PRNUS	Fast-food consumption by adolescent girls may sow the seeds..
2023/10/07	05:00	EDGAR2	Form 8-K - Current report
2023/9/29	05:28	EDGAR2	Form 8-K - Current report
2023/9/18	21:30	GLOBE	Atossa to Present at Cantor Fitzgerald Global Healthcare..
2023/8/14	21:35	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/14	21:30	EDGAR2	Form 8-K - Current report
2023/8/14	21:30	GLOBE	Atossa Therapeutics Announces Second Quarter 2023 Financial..
2023/8/08	22:00	GLOBE	Atossa Therapeutics to Provide Business Update and Report..
2023/7/20	22:15	GLOBE	Atossa Therapeutics Receives Approval from Health Canada to..
2023/7/14	05:20	EDGAR2	Form 8-K - Current report
2023/7/14	05:15	GLOBE	Atossa Therapeutics Regains Compliance with Nasdaq Minimum..
2023/7/10	22:15	GLOBE	Atossa Therapeutics Provides Enrollment Update for Ongoing..
2023/7/06	22:15	GLOBE	Atossa Therapeutics Announces Sponsored Research Agreement..
2023/6/28	22:15	PRNUS	Atossa Therapeutics and Quantum Leap Healthcare Provide..
2023/6/28	22:01	EDGAR2	Form 8-K - Current report